These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18166787)

  • 1. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
    Alavi S; Arzanian MT; Abbasian MR; Ashena Z
    Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
    Valcárcel D; Montesinos P; Sánchez-Ortega I; Brunet S; Esteve J; Martínez-Cuadrón D; Ribera JM; Tormo M; Bueno J; Duarte R; Llorente A; Torres JP; Guardia R; Sanz MA; Sierra AJ;
    Cancer; 2012 Jan; 118(2):410-7. PubMed ID: 21717435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
    Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach.
    Hsu HH; Chan YL; Huang CC
    J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
    Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
    Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
    Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
    Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
    Kedar A; Grow W; Neiberger RE
    Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum sodium in assessing hospital mortality in cancer patients with spontaneous tumour lysis syndrome inducing acute uric acid nephropathy.
    Hsu HH; Chen YC; Tian YC; Chan YL; Kuo MC; Tang CC; Fang JT; Lee SY; Yang CW
    Int J Clin Pract; 2009 May; 63(5):751-6. PubMed ID: 19402210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
    Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
    Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor lysis syndrome].
    Hagino T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
    Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
    J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.